Help Alan Carr with a point survey on COVID-19 vaccines!
Dear All, Once again, we’re going to have a brief change from our usual programming with this newsletter. I hope you recognize the name Alan Carr
29 September 2020
No Comments
R&D Insight
Mandatory reading: Alan Carr’s Jan 2020 Antibacterial and Antifungal market review
Dear All, Alan Carr has just released his Jan 2020 review of the antibacterial and antifungal market (link). For those of you not familiar with
28 January 2020
No Comments
Beyond the AMR Action Fund: PBS NewsHour and Things for us all to do!
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), While we’re all thrilled with the announcement of the AMR Action Fund (newsletter),
3 August 2020
No Comments
AMR Action Fund: A $1b down payment from Industry; A call for creation of strong Pull incentives
“The world is changed by your example, not by your opinion” (Paulo Coelho) Dear All, The AMR Action Fund (https://www.amractionfund.com/) announcement today was awesome …
9 July 2020
No Comments
CC4CARB solicitation is out (16 Mar 2020 deadline) / Superb WSJ podcast on antibiotic economics
Dear All, I wrote on 3 Jan 2020 (link) about the NIAID contract intended to establish an innovative Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). The
16 January 2020
No Comments
Lancet series video tour / Japan’s 2021 PPL (Priority Pathogen List)
Dear All, As a follow-up to yesterday’s relatively wonkish newsletter, I thought I’d quickly point out two things that may not have been obvious and
24 May 2024
No Comments
Path to UNGA 2024 as of 3 May 24 / Events on 14-15 May (DC, NYC)
Dear All, Well, ECCMID 2024 (Barcelona) has come and gone. I saw many of you there … but it’s always so busy … and the
3 May 2024
No Comments
NIAID/DMID thinking for FY2026: Antibacterials, Phage, and Antifungals
Dear All, NIAID’s DMID (Division of Microbiology and Infectious Diseases) recently held a council meeting during which they proposed program concepts that encompassed both antibacterial therapies
24 June 2024
No Comments
WHO call for data on pre-clinical antifungal R&D projects
Dear All, As part of their long-running project to maintain a useful view of the global antibacterial and antifungal pipelines, WHO yesterday announced a call
23 April 2024
No Comments
JPIAMR: AMR Interventions call for both fungi and bacteria!
Dear All, Happy New Year! I hope you were able to relax with friends and family during the year-end festivities! I have a small backlog
10 January 2024
No Comments